Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, El(26)a/28

Recall Summary Cadila Pharmaceuticals is recalling a batch of Mirtazapine 30mg tablets sold under the Crescent Pharma brand in the UK because the barcode on the carton is incorrect. The medication itself is not affected, only the labeling. This recall affects people in the United Kingdom who received tablets from this specific batch.

Recalling firm
Cadila Pharmaceuticals Limited
Reason
Cadila Pharmaceuticals Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg Film-Coated Tablets distributed in Crescent Pharma Limited livery.
Classification
Class III
Category
drug recall
Country
United Kingdom
Agency
UK Medicines and Healthcare products Regulatory Agency
Recall date
2026-06-08
Status
Ongoing
Distribution
United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/d839a747-02ed-4430-bc0e-032eafcc1cc0